These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15521022)

  • 21. Letter: Azathioprine-induced pancreatitis and subsequent tolerance of mercaptopurine--authors' reply.
    Kennedy NA; Lees CW
    Aliment Pharmacol Ther; 2014 Feb; 39(4):440-1. PubMed ID: 24447316
    [No Abstract]   [Full Text] [Related]  

  • 22. Initial clinical experience with allopurinol-thiopurine combination therapy in pediatric inflammatory bowel disease.
    Rahhal RM; Bishop WP
    Inflamm Bowel Dis; 2008 Dec; 14(12):1678-82. PubMed ID: 18521913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of 6-mercapturine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: con.
    Griffiths AM
    Inflamm Bowel Dis; 2005 Feb; 11(2):200-2. PubMed ID: 15677915
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
    Bouhnik Y; Lémann M; Mary JY; Scemama G; Taï R; Matuchansky C; Modigliani R; Rambaud JC
    Lancet; 1996 Jan; 347(8996):215-9. PubMed ID: 8551879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease.
    O'Brien JJ; Bayless TM; Bayless JA
    Gastroenterology; 1991 Jul; 101(1):39-46. PubMed ID: 2044925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Prefontaine E; Sutherland LR; Macdonald JK; Cepoiu M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000067. PubMed ID: 19160175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiopurines are negatively associated with anthropometric parameters in pediatric Crohn's disease.
    Gupta N; Lustig RH; Chao C; Vittinghoff E; Andrews H; Leu CS
    World J Gastroenterol; 2018 May; 24(18):2036-2046. PubMed ID: 29760546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [6-mercaptopurine levels and study of blood lymphocyte subsets during azathioprine treatment of Crohn's disease].
    Cattan S; Lémann M; Thuillier F; Bengoufa D; Rabian C; Ngo Y; Bouhnik Y; Messing B; Rambaud JC; Modigliani R
    Gastroenterol Clin Biol; 1998 Feb; 22(2):160-7. PubMed ID: 9762190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon.
    van Geenen EJ; de Boer NK; Stassen P; Linskens RK; Bruno MJ; Mulder CJ; Stegeman CA; van Bodegraven AA
    Aliment Pharmacol Ther; 2010 Jun; 31(12):1322-9. PubMed ID: 20222913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Crohn's disease.
    Greenfield S
    Lancet; 1996 May; 347(9010):1266-7. PubMed ID: 8622485
    [No Abstract]   [Full Text] [Related]  

  • 31. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae.
    Lowry PW; Weaver AL; Tremaine WJ; Sandborn WJ
    Inflamm Bowel Dis; 1999 Nov; 5(4):239-45. PubMed ID: 10579116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azathioprine and the treatment of chronic inflammatory bowel disease.
    Lloyd-Still JD
    J Pediatr; 1990 Nov; 117(5):732-5. PubMed ID: 2231203
    [No Abstract]   [Full Text] [Related]  

  • 34. Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine.
    Thomas CW; Lowry PW; Franklin CL; Weaver AL; Myhre GM; Mays DC; Tremaine WJ; Lipsky JJ; Sandborn WJ
    Inflamm Bowel Dis; 2003 Jul; 9(4):237-45. PubMed ID: 12902847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azathioprine or 6-mercaptopurine therapy and colon carcinoma in Crohn's disease.
    Zelig MP; Choi PM
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1448. PubMed ID: 1551566
    [No Abstract]   [Full Text] [Related]  

  • 36. 6-mercaptopurine as an alternative to azathioprine in azathioprine-induced hepatoxicity.
    Kiefer K; El-Matary W
    Inflamm Bowel Dis; 2009 Feb; 15(2):318-9. PubMed ID: 18989893
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease.
    Hassard PV; Vasiliauskas EA; Kam LY; Targan SR; Abreu MT
    Inflamm Bowel Dis; 2000 Feb; 6(1):16-20. PubMed ID: 10701145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Summary of the workshop on 6-mercaptopurine/azathioprine pharmacology.
    Markowitz JF
    Inflamm Bowel Dis; 1998 May; 4(2):117-8; discussion 118-20. PubMed ID: 9687220
    [No Abstract]   [Full Text] [Related]  

  • 39. Preventing relapse after surgery for Crohn's disease: where do we go from here?
    Bousvaros A
    J Pediatr Gastroenterol Nutr; 1997 Jul; 25(1):114-5. PubMed ID: 9226541
    [No Abstract]   [Full Text] [Related]  

  • 40. TPMT Testing Before Starting Azathioprine or Mercaptopurine: Surely Just Do It?
    Sanderson JD
    Gastroenterology; 2015 Oct; 149(4):850-3. PubMed ID: 26311276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.